US0980705018 - Common Stock
BONE BIOLOGICS CORP
NASDAQ:BBLG (5/3/2024, 9:35:02 AM)
1.81
-0.04 (-2.02%)
Bone Biologics Corp is a US-based company operating in Biotechnology industry. The company is headquartered in Burlington, Massachusetts and currently employs 2 full-time employees. The company went IPO on 2015-11-27. Bone Biologics Corporation is a medical device company. The firm is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. The NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. The NELL-1/DBM Fusion Device offers a range of procedures, including Spine Implants, Non-Union Trauma Cases and Osteoporosis. The NELL-1 is a function specific recombinant human protein that has been proven in laboratory bench models to recapitulate normal human growth and development to provide control over bone and cartilage regeneration. The firm develops platform technology through significant laboratories and small and large animal research to generate applications across fields of use. The platform technology is its recombinant human protein, known as NELL-1, a skeletal specific growth factor which is a bone void filler.
BONE BIOLOGICS CORP
2 Burlington Woods Dr Ste 100
Burlington MASSACHUSETTS
P: 17815524452
Employees: 2
Website: https://www.bonebiologics.com/
We're starting off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday morning!
Bone Biologics files prospectus for sale of common stock and warrant, clarifying it is not an offer to sell.
Here you can normally see the latest stock twits on BBLG, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: